These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6235814)

  • 1. Uracil enhancement of 5-fluorodexoyuridine incorporation into human breast carcinoma deoxyribonucleic acid.
    Kufe DW; Herrick D; Gunner L
    Biochem Pharmacol; 1984 Jul; 33(14):2329-31. PubMed ID: 6235814
    [No Abstract]   [Full Text] [Related]  

  • 2. Incorporation of 5-fluorodeoxycytidine and metabolites into nucleic acids of human MCF-7 breast carcinoma cells.
    Kaysen J; Spriggs D; Kufe D
    Cancer Res; 1986 Sep; 46(9):4534-8. PubMed ID: 2425957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical aspects of chemotherapy of mouse colon carcinoma: fluoropyrimidines and pyrazofurin.
    Brockman RW; Shaddix SC; Rose LM
    Cancer; 1977 Nov; 40(5 Suppl):2681-91. PubMed ID: 144558
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-Fluorouracil incorporation in DNA of human breast carcinoma cells.
    Major PP; Egan E; Herrick D; Kufe DW
    Cancer Res; 1982 Aug; 42(8):3005-9. PubMed ID: 6212116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulatory effects of inosine and deoxyinosine on the incorporation of uracil-2-14-C, 5-fluorouracil-2-14-C, and 5-bromouracil-2-14-C into nucleic acids by Ehrlich ascites tumor cells in vitro.
    Gotto AM; Belkhode ML; Touster O
    Cancer Res; 1969 Apr; 29(4):807-11. PubMed ID: 5775710
    [No Abstract]   [Full Text] [Related]  

  • 6. Determinants of human tumor sensitivity to fluorinated pyrimidine chemotherapy.
    Wolberg WH
    Ann Surg; 1967 Oct; 166(4):609-23. PubMed ID: 4228835
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of deoxyuridine triphosphate nucleotidohydrolase, uracil-DNA glycosylase, and DNA polymerase alpha in the metabolism of FUdR in human tumor cells.
    Caradonna SJ; Cheng YC
    Mol Pharmacol; 1980 Nov; 18(3):513-20. PubMed ID: 6110169
    [No Abstract]   [Full Text] [Related]  

  • 8. Irreversible enzyme inhibitors. CLXXI. Inhibition of FUDR phosphorylase from Walker 256 rat tumor by 5-substituted uracils.
    Baker BR; Kelley JL
    J Med Chem; 1970 May; 13(3):461-7. PubMed ID: 4245517
    [No Abstract]   [Full Text] [Related]  

  • 9. Irreversible enzyme inhibitors. CLXX. Inhibition of FUDR phosphorylase from Walker 256 rat tumor by 1-substituted uracils.
    Baker BR; Kelley JL
    J Med Chem; 1970 May; 13(3):458-61. PubMed ID: 4245516
    [No Abstract]   [Full Text] [Related]  

  • 10. Irreversible enzyme inhibitors. CLXIX. Inhibition of FUDR phosphorylase from Walker 256 rat tumor by 6-substituted uracils.
    Baker BR; Kelley JL
    J Med Chem; 1970 May; 13(3):456-8. PubMed ID: 4245515
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibitory effects of proflavine on the incorporation of DNA, RNA, and protein precursors in hamster melanoma].
    Balda BR; Birkmayer GD
    Arch Dermatol Forsch; 1972; 243(2):107-13. PubMed ID: 5066102
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical studies on human and rat breast tissues.
    Smith JA; King RJ; Meggitt BF; Allen LN
    Br J Cancer; 1966 Jun; 20(2):335-44. PubMed ID: 5944275
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some biochemical characteristics of rodent and human mammary carcinomas.
    Hilf R; Goldenberg H; Bell C; Michel I; Orlando RA; Archer FL
    Enzymol Biol Clin (Basel); 1970; 11(1):162-76. PubMed ID: 4313121
    [No Abstract]   [Full Text] [Related]  

  • 15. Will the best model of breast cancer please come forward?
    Hilf R
    Natl Cancer Inst Monogr; 1971 Dec; 34():43-54. PubMed ID: 4335260
    [No Abstract]   [Full Text] [Related]  

  • 16. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
    Ingraham HA; Tseng BY; Goulian M
    Mol Pharmacol; 1982 Jan; 21(1):211-6. PubMed ID: 6215571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A macrofluorescent and cytochemical study of dyshormonal hyperplasia and cancer of the breast].
    Mel'nik AN
    Arkh Patol; 1970; 32(12):32-7. PubMed ID: 4251879
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased incorporation of 5-fluorodeoxyuridine into DNA of human T-lymphoblastic cell lines.
    Tanaka M; Kimura K; Yoshida S
    Gan; 1984 Nov; 75(11):986-92. PubMed ID: 6151533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on certain cytoplasmic enzymes and specific estrogen receptors in human breast cancer and in nonmalignant diseases of the breast.
    Hilf R; Wittliff JL; Rector WD; Savlov ED; Hall TC; Orlando RA
    Cancer Res; 1973 Sep; 33(9):2054-62. PubMed ID: 4353478
    [No Abstract]   [Full Text] [Related]  

  • 20. Thymidine inhibits the incorporation of 5-fluoro-2'-deoxyuridine to DNA of mouse mammary tumour.
    Nayak R
    Biochem Biophys Res Commun; 1992 Apr; 184(1):467-70. PubMed ID: 1533124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.